| 1 | Post-Transplant Lymphoproliferative Disorder at the Porta Hepatis Causing Hepatic Artery Stenosis and Cholestasis. (Rawashdeh B, Papageorge C, Al-Adwan Y) Am J Case Rep 2025 Jan 23;26:e945837 |
| 1 | Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation. (Böhm S, Wustrau K, Pachlopnik Schmid J, Prader S, Ahlmann M, Yacobovich J, Beier R, Speckmann C, Behnisch W, Ifversen M, Jordan M, Marsh R, Naumann-Bartsch N, Mauz-Körholz C, Hönig M, Schulz A, Malinowska I, Hines M, Nichols KE, Gil-Herrera J, Talano JA, Crooks B, Formankova R, Jorch N, Bakhtiar S, Kühnle I, Streiter M, Nathrath M, Russo A, Dürken M, Lang P, Lindemans C, Henter JI, Lehmberg K, Ehl S) Blood 2024 Mar 07;143(10):872-881 15 Citations |
| 2 | Post-transplant primary cutaneous peripheral T-cell lymphoma not otherwise specified in a pediatric patient. (Cardwell LA, Majerowski J, Chiu YE, Harrington AM, Sokumbi O) J Cutan Pathol 2021 May;48(5):706-712 3 Citations |
| 1 | Long-term outcomes of pediatric kidney transplant recipients with a pretransplant malignancy. (Serrano OK, Gannon A, Olowofela AS, Reddy A, Berglund D, Matas AJ) Pediatr Transplant 2019 Nov;23(7):e13557 5 Citations |
| 3 | Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study. (Naik S, Riches M, Hari P, Kim S, Chen M, Bachier C, Shaughnessy P, Hill J, Ljungman P, Battiwalla M, Chhabra S, Daly A, Storek J, Ustun C, Diaz MA, Cerny J, Beitinjaneh A, Yared J, Brown V, Page K, Dahi PB, Ganguly S, Seo S, Chao N, Freytes CO, Saad A, Savani BN, Woo Ahn K, Boeckh M, Heslop HE, Lazarus HM, Auletta JJ, Kamble RT) Transpl Infect Dis 2019 Oct;21(5):e13145 22 Citations |
| 1 | X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia. (Blackburn PR, Lin WL, Miller DA, Lorenzo-Betancor O, Edwards ES, Zimmermann MT, Farrugia LP, Freeman WD, Soto AI, Walton RL, Klee EW, Atwal PS, Abraham RS, Billadeau DD, Ross OA, Dickson DW, Meschia JF) J Neuropathol Exp Neurol 2019 May 01;78(5):460-466 8 Citations |
| 3 | CD30 Expression in Monomorphic Posttransplant Lymphoproliferative Disorder, Diffuse Large B-Cell Lymphoma Correlates With Greater Regulatory T-Cell Infiltration. (Hartley C, Vaughan JW, Jarzembowski J, Kroft SH, Hosking P, Harrington AM, Olteanu H) Am J Clin Pathol 2017 Nov 20;148(6):485-493 11 Citations |
| 1 | Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia. (Tompkins VS, Sompallae R, Rosean TR, Walsh S, Acevedo M, Kovalchuk AL, Han SS, Jing X, Holman C, Rehg JE, Herms S, Sunderland JS, Morse HC, Janz S) Blood Cancer J 2016 Nov 04;6(11):e488 3 Citations |
| 3 | Intact Regulatory T-Cell Function but Defective Generation of IL-17A-Producing CD4+ T Cells in XIAP Deficiency. (Gurram B, Hammelev E, Syverson G, Haribhai D, Yan K, Simpson P, Salzman N, Verbsky JW) J Pediatr Gastroenterol Nutr 2016 Aug;63(2):218-25 |
| 1 | Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure. (Ayas M, Eapen M, Le-Rademacher J, Carreras J, Abdel-Azim H, Alter BP, Anderlini P, Battiwalla M, Bierings M, Buchbinder DK, Bonfim C, Camitta BM, Fasth AL, Gale RP, Lee MA, Lund TC, Myers KC, Olsson RF, Page KM, Prestidge TD, Radhi M, Shah AJ, Schultz KR, Wirk B, Wagner JE, Deeg HJ) Biol Blood Marrow Transplant 2015 Oct;21(10):1790-5 4 Citations |
| 1 | Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature. (Ferguson NN, Thomas CP, Hohl RJ, Syrbu SI, Stone MS, Wanat KA) Am J Dermatopathol 2015 Oct;37(10):790-4 7 Citations |
| 1 | Mutlifocal osseous posttransplantation lymphoproliferative disorder: case report. (Lo R, Michalicek Z, Lazarus M) Skeletal Radiol 2015 Jul;44(7):1021-6 |
| 1 | Post-transplant lymphoproliferative disorders. (Singavi AK, Harrington AM, Fenske TS) Cancer Treat Res 2015;165:305-27 82 Citations |
| 1 | Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. (Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, Lyons JJ, Engelhardt KR, Zhang Y, Topcagic N, Roberson ED, Matthews H, Verbsky JW, Dasu T, Vargas-Hernandez A, Varghese N, McClain KL, Karam LB, Nahmod K, Makedonas G, Mace EM, Sorte HS, Perminow G, Rao VK, O'Connell MP, Price S, Su HC, Butrick M, McElwee J, Hughes JD, Willet J, Swan D, Xu Y, Santibanez-Koref M, Slowik V, Dinwiddie DL, Ciaccio CE, Saunders CJ, Septer S, Kingsmore SF, White AJ, Cant AJ, Hambleton S, Cooper MA) Blood 2015 Jan 22;125(4):591-9 452 Citations |
| 1 | Eosinophilic esophagitis in children following cardiac transplantation: association with post-transplant lymphoproliferative disorder and other transplant outcomes. (Kindel SJ, Joy BF, Pahl E, Wald EL) Pediatr Transplant 2014 Aug;18(5):491-6 7 Citations |
| 1 | EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era. (Fox CP, Burns D, Parker AN, Peggs KS, Harvey CM, Natarajan S, Marks DI, Jackson B, Chakupurakal G, Dennis M, Lim Z, Cook G, Carpenter B, Pettitt AR, Mathew S, Connelly-Smith L, Yin JA, Viskaduraki M, Chakraverty R, Orchard K, Shaw BE, Byrne JL, Brookes C, Craddock CF, Chaganti S) Bone Marrow Transplant 2014 Feb;49(2):280-6 77 Citations |
| 1 | Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients. (Karuturi M, Shah N, Frank D, Fasan O, Reshef R, Ahya VN, Bromberg M, Faust T, Goral S, Schuster SJ, Stadtmauer EA, Tsai DE) Transpl Int 2013 Jun;26(6):616-22 34 Citations |
| 1 | Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. (Marsh RA, Rao K, Satwani P, Lehmberg K, Müller I, Li D, Kim MO, Fischer A, Latour S, Sedlacek P, Barlogis V, Hamamoto K, Kanegane H, Milanovich S, Margolis DA, Dimmock D, Casper J, Douglas DN, Amrolia PJ, Veys P, Kumar AR, Jordan MB, Bleesing JJ, Filipovich AH) Blood 2013 Feb 07;121(6):877-83 131 Citations |
| 1 | Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation. (Twombley K, Pokala H, Ardura MI, Harker-Murray P, Johnson-Welch SF, Weinberg A, Seikaly M) Pediatr Transplant 2012 Sep;16(6):E201-9 16 Citations |
| 2 | Epicardial lymphoproliferative disease involving the coronary arteries. (von Ballmoos MC, Masroor S, Murtaza G, Franco J, Gasparri M, Rubenstein JC) J Am Coll Cardiol 2011 Oct 18;58(17):1825 |
| 1 | Castleman's disease: from basic mechanisms to molecular therapeutics. (El-Osta HE, Kurzrock R) Oncologist 2011;16(4):497-511 125 Citations |
| 2 | Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007. (Ahmed SO, Ghavamzadeh A, Zaidi SZ, Baldomero H, Pasquini MC, Hussain F, Alimoghaddam K, Almohareb F, Ayas M, Hamidieh A, Mahmoud HK, Elhaddad A, Ben Othman T, Abdelkefi A, Sarhan M, Abdel-Rahman F, Adil S, Alkindi S, Bazarbachi A, Benchekroun S, Niederwieser D, Horowitz M, Gratwohl A, El Solh H, Aljurf M) Biol Blood Marrow Transplant 2011 Sep;17(9):1352-61 16 Citations |
| 2 | Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy. (Olteanu H, Schur BC, Bredeson C, Atallah E, Kroft SH) Leuk Lymphoma 2010 Mar;51(3):481-7 5 Citations |
| 1 | Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets. (Morice WG, Jevremovic D, Olteanu H, Roden A, Nowakowski G, Kroft S, Hanson CA, Kurtin PJ) Leukemia 2010 Apr;24(4):881-4 38 Citations |
| 2 | Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. (Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE) Blood 2009 May 14;113(20):4992-5001 352 Citations |
| 2 | X-linked lymphoproliferative disease in an EBV-negative patient presenting with pancytopenia. (Kapadia SB, Macginnitie AJ, Shaw PH) Pediatr Blood Cancer 2008 Jun;50(6):1296-7 2 Citations |
| 1 | Murine gammaherpesvirus 68 genes both induce and suppress lymphoproliferative disease. (Tarakanova VL, Kreisel F, White DW, Virgin HW 4th) J Virol 2008 Jan;82(2):1034-9 29 Citations |
| 1 | Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma. (Williams KM, Higman MA, Chen AR, Schwartz CL, Wharam M, Colombani P, Arceci RJ) Pediatr Blood Cancer 2008 Mar;50(3):667-70 22 Citations |
| 1 | Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR. (Hamadani M, Martin LK, Benson DM, Copelan EA, Devine SM, Hofmeister CC) Bone Marrow Transplant 2007 Feb;39(4):249-51 20 Citations |
| 1 | Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice. (Tarakanova VL, Suarez F, Tibbetts SA, Jacoby MA, Weck KE, Hess JL, Speck SH, Virgin HW 4th) J Virol 2005 Dec;79(23):14668-79 98 Citations |
| 1 | Chromophobe renal cell carcinoma in a pediatric living-related kidney transplant recipient. (Greco AJ, Baluarte JH, Meyers KE, Sellers MT, Suchi M, Biegel JA, Kaplan BS) Am J Kidney Dis 2005 Jun;45(6):e105-8 22 Citations |
| 1 | Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder. (Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnahan BA, Hariharan S) Clin Transplant 2003 Oct;17(5):417-22 81 Citations |
| 1 | Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders. (Abed N, Casper JT, Camitta BM, Margolis D, Trost B, Orentas R, Chang CC) Bone Marrow Transplant 2004 Feb;33(3):321-7 15 Citations |
| 1 | Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients. (Orentas RJ, Schauer DW Jr, Ellis FW, Walczak J, Casper JT, Margolis DA) Pediatr Transplant 2003 Aug;7(4):305-14 39 Citations |
| 1 | Comparative tolerability of systemic treatments for plaque-type psoriasis. (McClure SL, Valentine J, Gordon KB) Drug Saf 2002;25(13):913-27 63 Citations |
| 1 | X-linked lymphoproliferative disease: genetic lesions and clinical consequences. (MacGinnitie AJ, Geha R) Curr Allergy Asthma Rep 2002 Sep;2(5):361-7 10 Citations |
| 1 | Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation. (Haut PR, Kovarik P, Shaw PH, Walterhouse D, Jenson HB, Kletzel M) Bone Marrow Transplant 2001 Apr;27(7):761-5 17 Citations |
| 1 | Posttransplantation lymphoproliferative disease in children: otolaryngologic manifestations and management. (Posey LA, Kerschner JE, Conley SF) South Med J 1999 Nov;92(11):1079-82 12 Citations |
| 1 | Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. (Curtis RE, Travis LB, Rowlings PA, Socié G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ) Blood 1999 Oct 01;94(7):2208-16 599 Citations |
| 1 | Interleukin-6: biologic properties and role in lymphoproliferative disorders. (Seymour JF, Kurzrock R) Cancer Treat Res 1996;84:167-206 10 Citations |
| 1 | 2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders. (O'Brien S, Kurzrock R, Duvic M, Kantarjian H, Stass S, Robertson LE, Estey E, Pierce S, Keating MJ) Blood 1994 Aug 01;84(3):733-8 68 Citations |
